Among all of the DNA repair biomarkers that we analyzed, XPF was the single best marker to predict response to induction chemotherapy by univariate analysis; low levels of expression of XPF in head and neck cancer patients were associated with better response to induction chemotherapy. This evidence concerns the gene ERCC4 and head and neck cancer.